Literature DB >> 3948091

Long-term study of the safety of the Dalkon Shield and Gyne-T 200 intrauterine devices.

J E Rioux, D Cloutier, P Dupont, D Lamonde.   

Abstract

Between 1971 and 1973, 200 Dalkon Shield and 142 Gyne-T 200 intrauterine devices (IUDs) were inserted at the department of obstetrics and gynecology in a large urban hospital. In 1984 retrospective analysis of events associated with the use of these IUDs was done. Hospital and clinic charts were reviewed, and the women were contacted to obtain information on infertility and the outcome of pregnancy after discontinuation of IUD use. The rates of events leading to discontinuation of IUD use 2 years after insertion were similar in the two groups except for that of planned pregnancy, which was higher in the Dalkon Shield users (p less than 0.05). The rates of accidental pregnancy per 100 women were 3.8 for the Dalkon Shield users and 1 for the Gyne-T 200 users. The rates of pelvic inflammatory disease (PID) based on all cases of PID and follow-up information were similar in the two groups. There were no differences between the two groups in outcome of pregnancy with the IUD in situ or after expulsion or removal of the IUD because of planned pregnancy or other reasons. Infertility rates after discontinuation of IUD use were similar for the Dalkon Shield and Gyne-T 200 users. The results confirm the authors' opinion that the Dalkon Shield and Gyne-T 200 IUDs are safe and effective methods of intrauterine contraception.

Entities:  

Mesh:

Year:  1986        PMID: 3948091      PMCID: PMC1492461     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  21 in total

1.  The etiology of pelvic inflammatory disease.

Authors:  L Keith; G S Berger
Journal:  Res Front Fertil Regul       Date:  1984-05

2.  THE MARGULIES INTRAUTERINE CONTRACEPTIVE DEVICE: EXPERIENCE WITH 623 WOMEN.

Authors:  J R WILLSON; W J LEDGER; C C BOLLINGER; G J ANDROS
Journal:  Am J Obstet Gynecol       Date:  1965-05-01       Impact factor: 8.661

3.  Some suggested improvements to current statistical methods of analyzing contraceptive efficacy.

Authors:  S P Azen; S Roy; M C Pike; J Casagrande
Journal:  J Chronic Dis       Date:  1976-10

4.  The Dalkon Shield, the TCu 200, and the TCu 380A in private practice.

Authors:  W O Thomas
Journal:  Trans Pac Coast Obstet Gynecol Soc       Date:  1977

5.  In vitro study of the possible role of the intrauterine contraceptive device tail in ascending infection of the genital tract.

Authors:  B G Purrier; R A Sparks; P J Watt; M Elstein
Journal:  Br J Obstet Gynaecol       Date:  1979-05

6.  Evaluation of intrauterine devices: ninth progress report of the Cooperative Statistical Program.

Authors:  C Tietze
Journal:  Stud Fam Plann       Date:  1970-07

7.  A study of the intrauterine contraceptive device with and without an extracervical appendage or tail.

Authors:  M I Buchman
Journal:  Fertil Steril       Date:  1970-04       Impact factor: 7.329

8.  Pelvic inflammation and the intrauterine contraceptive device.

Authors:  M Elstein; C Birnberg; W Mills; P Eckstein
Journal:  Proc R Soc Med       Date:  1967-04

9.  Randomized comparative study of the copper T 300, Dalkon shield, and Shell Loop in parous women.

Authors:  D L Cooper; R Israel; D R Mishell
Journal:  Obstet Gynecol       Date:  1975-05       Impact factor: 7.661

10.  The Dalkon Shield controversy. Structural and bacteriological studies of IUD tails.

Authors:  H J Tatum; F H Schmidt; D Phillips; M McCarty; W M O'Leary
Journal:  JAMA       Date:  1975-02-17       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.